News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
194,005 Results
Type
Article (8026)
Company Profile (12)
Press Release (185967)
Multimedia
Podcasts (7)
Webinars (6)
Section
Business (75851)
Career Advice (451)
Deals (10971)
Drug Delivery (16)
Drug Development (21970)
Employer Resources (52)
FDA (4154)
Job Trends (4047)
News (112283)
Policy (8139)
Tag
Academia (681)
Adcomms (11)
Allergies (25)
Alliances (13046)
ALS (16)
Alzheimer's disease (417)
Antibody-drug conjugate (ADC) (30)
Approvals (4200)
Artificial intelligence (68)
Autoimmune disease (1)
Automation (3)
Bankruptcy (72)
Best Places to Work (3427)
BIOSECURE Act (3)
Biosimilars (17)
Biotechnology (8)
Bladder cancer (17)
Brain cancer (7)
Breast cancer (59)
Cancer (614)
Cardiovascular disease (34)
Career advice (380)
Career pathing (10)
CAR-T (28)
Cell therapy (98)
Cervical cancer (7)
Clinical research (18487)
Collaboration (232)
Compensation (28)
Complete response letters (2)
COVID-19 (508)
CRISPR (13)
C-suite (91)
Cystic fibrosis (21)
Data (644)
Decentralized trials (1)
Denatured (3)
Depression (5)
Diabetes (78)
Diagnostics (1987)
Digital health (5)
Diversity (1)
Diversity, equity & inclusion (15)
Drug discovery (29)
Drug pricing (14)
Drug shortages (2)
Duchenne muscular dystrophy (15)
Earnings (42776)
Editorial (4)
Employer branding (8)
Employer resources (47)
Events (27246)
Executive appointments (219)
FDA (4510)
Frontotemporal dementia (3)
Funding (138)
Gene editing (25)
Generative AI (7)
Gene therapy (70)
GLP-1 (123)
Government (959)
Grass and pollen (1)
Guidances (81)
Healthcare (5016)
Huntington's disease (1)
IgA nephropathy (2)
Immunology and inflammation (17)
Indications (12)
Infectious disease (543)
Inflammatory bowel disease (35)
Influenza (14)
Intellectual property (25)
Interviews (67)
IPO (5595)
IRA (2)
Job creations (800)
Job search strategy (348)
Kidney cancer (7)
Labor market (2)
Layoffs (73)
Leadership (5)
Legal (1493)
Liver cancer (20)
Lung cancer (108)
Lymphoma (45)
Machine learning (1)
Management (19)
Manufacturing (76)
MASH (6)
Medical device (4166)
Medtech (4166)
Mergers & acquisitions (5480)
Metabolic disorders (143)
Multiple sclerosis (21)
Neurodegenerative disease (17)
Neuropsychiatric disorders (2)
Neuroscience (540)
NextGen: Class of 2025 (1583)
Non-profit (1201)
Now hiring (2)
Obesity (69)
Opinion (41)
Ovarian cancer (25)
Pain (14)
Pancreatic cancer (18)
Parkinson's disease (55)
Partnered (1)
Patents (40)
Patient recruitment (26)
Peanut (17)
People (18730)
Pharmaceutical (8)
Phase I (4905)
Phase II (7795)
Phase III (7020)
Pipeline (518)
Policy (12)
Postmarket research (793)
Preclinical (2007)
Press Release (12)
Prostate cancer (28)
Psychedelics (2)
Radiopharmaceuticals (83)
Rare diseases (74)
Real estate (1486)
Recruiting (19)
Regulatory (6219)
Reports (8)
Research institute (641)
Resumes & cover letters (63)
Rett syndrome (1)
RSV (11)
Schizophrenia (19)
Series A (25)
Series B (19)
Service/supplier (1)
Sickle cell disease (11)
Spinal muscular atrophy (28)
Sponsored (7)
Startups (759)
Stomach cancer (4)
Supply chain (14)
Tariffs (7)
The Weekly (4)
Vaccines (146)
Venture capitalists (6)
Weight loss (32)
Women's health (5)
Worklife (5)
Date
Last 7 days (310)
Last 30 days (892)
Last 365 days (8387)
2025 (3007)
2024 (9416)
2023 (11388)
2022 (15121)
2021 (16421)
2020 (15716)
2019 (13587)
2018 (10408)
2017 (10561)
2016 (9575)
2015 (11829)
2014 (8372)
2013 (6483)
2012 (7122)
2011 (7616)
2010 (6677)
Location
Africa (250)
Alabama (6)
Arizona (33)
Arkansas (1)
Asia (14366)
Australia (2615)
California (1469)
Canada (571)
China (203)
Colorado (69)
Connecticut (46)
Delaware (44)
Europe (31351)
Florida (260)
Georgia (50)
Idaho (23)
Illinois (130)
India (8)
Indiana (99)
Iowa (1)
Japan (85)
Kansas (22)
Kentucky (5)
Louisiana (7)
Maine (39)
Maryland (196)
Massachusetts (1021)
Michigan (73)
Minnesota (108)
Missouri (19)
Montana (12)
Nebraska (6)
Nevada (25)
New Hampshire (24)
New Jersey (560)
New Mexico (5)
New York (410)
North Carolina (288)
North Dakota (2)
Northern California (613)
Ohio (55)
Oklahoma (3)
Oregon (4)
Pennsylvania (366)
Puerto Rico (4)
Rhode Island (5)
South America (436)
South Carolina (9)
Southern California (635)
Tennessee (19)
Texas (186)
United States (5795)
Utah (56)
Virginia (21)
Washington D.C. (12)
Washington State (147)
West Virginia (1)
Wisconsin (17)
194,005 Results for "cordenpharma international".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
CordenPharma Expands GLP-1 Manufacturing Footprint in US and Europe with $980M Commitment
To help keep pace with the demand for GLP-1 therapies, CordenPharma has announced a sizeable $980 million investment in its U.S. and European sites.
July 16, 2024
·
2 min read
·
Tristan Manalac
Press Releases
CordenPharma and Viking Therapeutics Sign Long-Term Strategic Partnership for Integrated Supply of GLP-1 Peptides, Injectables and Oral Formulations
March 11, 2025
·
3 min read
Press Releases
CordenPharma Expands Peptide Platform with more than 500 Million Euro Greenfield Facility Construction in the Basel Region of Switzerland
March 5, 2025
·
6 min read
Press Releases
CordenPharma Invests €900m in Transformational Peptide Platform Expansion in the USA & Europe
July 16, 2024
·
5 min read
Press Releases
WACKER & CordenPharma Enter Pandemic Readiness on 1 June 2024 After Successful Expansion & Qualification
June 19, 2024
·
5 min read
CordenPharma Establishes World-Class Technology & Science Advisory Board of Experts Across Six Technology Platforms
CordenPharma has created a new Technology & Science Advisory Board with eight world-class experts from academia and industry, who will provide strategic guidance and scientific expertise to drive forward the company’s continued growth and innovation.
July 26, 2023
·
4 min read
Deals
CordenPharma Completes Acquisition of Three Manufacturing Facilities from Vifor Pharma
CordenPharma announced the completion of the acquisition of three manufacturing facilities from Vifor Pharma, to be ultimately renamed Corden Pharma Fribourg S.A. in Switzerland, and Corden Pharma Lisbon S.A. in Portugal.
February 1, 2022
·
2 min read
Business
Vifor Pharma drives transformation with divestment of non-core finished drug manufacturing to CordenPharma
Vifor Pharma Group today announced the divestment of its finished drug product manufacturing business to CordenPharma.
December 16, 2021
·
5 min read
Press Releases
ACP and Annals of Internal Medicine present breaking scientific news at ACP’s Internal Medicine Meeting 2025
April 4, 2025
·
4 min read
Press Releases
Gossamer Bio to Present Preclinical Data at the American Thoracic Society (ATS) 2025 International Conference
May 8, 2025
·
1 min read
1 of 19,401
Next
